Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

dc.contributor.authorGarrido, P.
dc.contributor.authorAldaz, Azucena
dc.contributor.authorVera, R.
dc.contributor.authorCalleja, M. A.
dc.contributor.authorÁlava, Enrique de
dc.contributor.authorMartín, M.
dc.contributor.authorMatias-Guiu, Xavier, 1958-
dc.contributor.authorPalacios, José
dc.date.accessioned2020-12-17T13:36:40Z
dc.date.available2020-12-17T13:36:40Z
dc.date.issued2018-04-01
dc.date.updated2020-12-04T12:33:19Z
dc.description.abstractPrecision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational, and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals, and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology, Pathology, and Hospital Pharmacy, we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid28861725
dc.identifier.urihttps://hdl.handle.net/2445/172841
dc.language.isoeng
dc.publisherSpringer
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1007/s12094-017-1740-0
dc.relation.ispartofClinical & Translational Oncology, 2018, vol. 20, num. 4, p. 443-447
dc.relation.urihttps://doi.org/10.1007/s12094-017-1740-0
dc.rightscc by (c) Garrido et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationOncologia
dc.subject.classificationMedicina personalitzada
dc.subject.otherOncology
dc.subject.otherPersonalized medicine
dc.titleProposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
GarridoP.pdf
Mida:
345.99 KB
Format:
Adobe Portable Document Format